Esomeprazole
- TRADE NAME: Nexium (AstraZeneca)
- INDICATIONS: Gastroesophageal reflux disease
- CLASS: Proton pump inhibitor (PPI)
- HALF-LIFE: 1.5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Benzodiazepines, Chlordiazepoxide, Cilostazol, Clonazepam, Clopidogrel, Clorazepate, Diazepam, Digoxin, Emtricitabine/Rilpivirine/Tenofovir Alafenamide, Flurazepam, Lorazepam, Midazolam, Oxazepam, Posaconazole, Quazepam, Rifampin, Rilpivirine, St John's Wort, Temazepam, Tipranavir, Voriconazole
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
